// App-Quantinova.ai

2605 : Clofarabine in Pediatric Patients with Refractory or Relapsed Leukemia: the GATLA experience.

Researchers

Presenter

  • Cecilia Riccheri

Principal Investigators

  • Sergio Gomez

  • Graciela Onelda Elena

  • Guillermo Arbesu

  • Carlos Hollmann

  • Bibiana Tramunt

  • Mercedes Tomasetti

  • Sandra Zirone

  • Nestor Rossi

  • Daniel Freigeiro

  • Luis Alberto Aversa

  • Marcela Gutierrez

  • Alcira Fynn

  • Virginia Schuttenberg

  • Alejandra Cedola

  • Constanza Drozdowski

  • Horacio Caferri

  • Julieta Bietti

Medical Centers

  • GATE-D, Buenos Aires, Argentina

Locations

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Clofarabine

  • Etoposide

  • Etoposide phosphate

  • ara-c

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved